InvestorsHub Logo
Followers 44
Posts 3171
Boards Moderated 2
Alias Born 01/18/2016

Re: None

Monday, 09/25/2017 10:58:04 AM

Monday, September 25, 2017 10:58:04 AM

Post# of 233
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), the leading RNAi therapeutics company, today announced that the Company presented new pre-clinical data highlighting its next generation “Enhanced Stabilization Chemistry Plus” (ESC+) GalNAc-siRNA conjugate platform at the 13th Annual Meeting of the Oligonucleotide Therapeutics Society (OTS), held September 24 – 27, 2017 in Bordeaux, France.


Arriba, Abajo, al Centro, y pa’dentro!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ALNY News